Indonesia Kendaraan Terminal Tbk vs Organon Pharma Indonesia Tbk. — how do they compare? Indonesia Kendaraan Terminal Tbk trades at Rp1,125 (market cap 2.05T, 770K 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Indonesia Kendaraan Terminal Tbk is far larger — about 19.6× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| IPCC | SCPI | |
|---|---|---|
Market Cap | 2.05T | 104.4B |
Volume | 770K | — |
Lot | 7.7K | — |
Turnover | 864.05M | — |
Average Price | 1,122.14 | — |
Value | 864.05M | — |
Indicative Equilibrium Price | 1,125 | — |
Indicative Equilibrium Volume | 20 | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Indonesia Kendaraan Terminal Tbk (“the Company”) was established based on November 05, 2012 by deed No. 10 of Yulianti Irawati SH., substitute of Nur Muhammad Dipo Nusantara Pua Upa, S.H., M.Kn., Notary in Jakarta. Prior to becoming a separate business entity, PT Indonesia Vehicle Terminal was only a strategic business unit called Tanjung Priok Car Terminal (TPT) under its Head Office and operated since June 2007.
Read more on IPCC →PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →